search button
Open Access

[Retracted] miR‑663 promotes NPC cell proliferation by directly targeting CDKN2A

  • Authors:
    • Shaoqiang Liang
    • Ning Zhang
    • Yanming Deng
    • Lusi Chen
    • Yang Zhang
    • Zhenhe Zheng
    • Weijun Luo
    • Zhiqian Lv
    • Shaoen Li
    • Tao Xu

  • View Affiliations

  • Published online on: November 22, 2021     https://doi.org/10.3892/mmr.2021.12539
  • Article Number: 23

  • Copyright : © Liang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

January-2022
Volume 25 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
  • CiteScore: 6.9
  • CiteScore Rank: Q2: #98/328 Biochemistry, Genetics and Molecular Biology
  • Source Normalized Impact per Paper (SNIP): 0.721
  • SCImago Journal Rank (SJR): 0.65
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Liang S, Zhang N, Deng Y, Chen L, Zhang Y, Zheng Z, Luo W, Lv Z, Li S, Xu T, Xu T, et al: [Retracted] miR‑663 promotes NPC cell proliferation by directly targeting CDKN2A. Mol Med Rep 25: 23, 2022
APA
Liang, S., Zhang, N., Deng, Y., Chen, L., Zhang, Y., Zheng, Z. ... Xu, T. (2022). [Retracted] miR‑663 promotes NPC cell proliferation by directly targeting CDKN2A. Molecular Medicine Reports, 25, 23. https://doi.org/10.3892/mmr.2021.12539
MLA
Liang, S., Zhang, N., Deng, Y., Chen, L., Zhang, Y., Zheng, Z., Luo, W., Lv, Z., Li, S., Xu, T."[Retracted] miR‑663 promotes NPC cell proliferation by directly targeting CDKN2A". Molecular Medicine Reports 25.1 (2022): 23.
Chicago
Liang, S., Zhang, N., Deng, Y., Chen, L., Zhang, Y., Zheng, Z., Luo, W., Lv, Z., Li, S., Xu, T."[Retracted] miR‑663 promotes NPC cell proliferation by directly targeting CDKN2A". Molecular Medicine Reports 25, no. 1 (2022): 23. https://doi.org/10.3892/mmr.2021.12539